Paper · 40201239
Computational analysis of the structural-functional dynamics of a Co-receptor proteoglycan.
Tavanti F and 2 others. Front Mol Biosci, 2025. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Computational analysis of the structural-functional dynamics of a Co-receptor proteoglycan. Papers, record 40201239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40201239
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Computational analysis of the structural-functional dynamics of a Co-receptor proteoglycan.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 40,458,264 | Corrigendum: Computational analysis of the structural-functional dynamics of a Co-receptor proteoglycan. | https://conductscience.org/library/papers/40458264 |
Source PubMed
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30,525,595 | CHARMM-GUI Membrane Builder for Complex Biological Membrane Simulations with Glycolipids and Lipoglycans. | J Chem Theory Comput | 2019 | https://conductscience.org/library/papers/30525595 | PubMed |
| 2 | 26,621,095 | The MARTINI Coarse-Grained Force Field: Extension to Proteins. | J Chem Theory Comput | 2008 | https://conductscience.org/library/papers/26621095 | PubMed |
| 3 | 8,714,520 | Interaction between NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells is required for optimal response to PDGF. | J Neurosci Res | 1996 | https://conductscience.org/library/papers/8714520 | PubMed |
| 4 | 12,514,214 | Multiple regions of the NG2 proteoglycan inhibit neurite growth and induce growth cone collapse. | J Neurosci | 2003 | https://conductscience.org/library/papers/12514214 | PubMed |
| 5 | 10,358,027 | High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10358027 | PubMed |
| 6 | 35,324,891 | Structural dynamics of receptor recognition and pH-induced dissociation of full-length Clostridioides difficile Toxin B. | PLoS Biol | 2022 | https://conductscience.org/library/papers/35324891 | PubMed |
| 7 | 39,103,332 | Rescaling protein-protein interactions improves Martini 3 for flexible proteins in solution. | Nat Commun | 2024 | https://conductscience.org/library/papers/39103332 | PubMed |
| 8 | 30,550,356 | Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality. | FASEB J | 2019 | https://conductscience.org/library/papers/30550356 | PubMed |
| 9 | 28,715,802 | Nerve/Glial Antigen 2: A Novel Target for Anti-Tumor Therapy in Colorectal Cancer. | Digestion | 2017 | https://conductscience.org/library/papers/28715802 | PubMed |
| 10 | 29,812,912 | Proximity Labeling by a Recombinant APEX2-FGF1 Fusion Protein Reveals Interaction of FGF1 with the Proteoglycans CD44 and CSPG4. | Biochemistry | 2018 | https://conductscience.org/library/papers/29812912 | PubMed |
1 to 10 of 63
See all 63 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,244,107 | A computational analysis of the glycoprotein lipoprotein receptor-related protein 1 structure and the role of glycans as quaternary glue. | Bioinformatics | 2026 | https://conductscience.org/library/papers/42244107 |
Source PubMed
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CSPG4 | 1,464 | PubTator's text mining | https://conductscience.org/library/genes/1464 | NCBI Gene |
| FGF2 | 2,247 | PubTator's text mining | https://conductscience.org/library/genes/2247 | NCBI Gene |
| FGFR1 | 2,260 | PubTator's text mining | https://conductscience.org/library/genes/2260 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40201239
GET https://conductscience.org/api/papers/v1/40201239/references?page=2